U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Tuberous xanthoma

MedGen UID:
86213
Concept ID:
C0302164
Disease or Syndrome
Synonym: Xanthoma tuberosum
SNOMED CT: Xanthoma tuberosum (238954002); Tuberous xanthoma (238954002)
 
HPO: HP:0031290

Definition

A type of xanthoma characterized by a nodular form. Tuberous xanthomas are firm subcutaneous nodules,whereby the overlying skin can have red or red-yellow color changes. [from HPO]

Term Hierarchy

Conditions with this feature

Cholestanol storage disease
MedGen UID:
116041
Concept ID:
C0238052
Disease or Syndrome
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures). Chronic diarrhea from infancy and/or neonatal cholestasis may be the earliest clinical manifestation. In approximately 75% of affected individuals, cataracts are the first finding, often appearing in the first decade of life. Xanthomas appear in the second or third decade; they occur on the Achilles tendon, the extensor tendons of the elbow and hand, the patellar tendon, and the neck tendons. Xanthomas have been reported in the lung, bones, and central nervous system. Some individuals show cognitive impairment from early infancy, whereas the majority have normal or only slightly impaired intellectual function until puberty; dementia with slow deterioration in intellectual abilities occurs in the third decade in more than 50% of individuals. Neuropsychiatric symptoms such as behavioral changes, hallucinations, agitation, aggression, depression, and suicide attempts may be prominent. Pyramidal signs (i.e., spasticity) and/or cerebellar signs almost invariably become evident between ages 20 and 30 years. The biochemical abnormalities that distinguish CTX from other conditions with xanthomas include high plasma and tissue cholestanol concentration, normal-to-low plasma cholesterol concentration, decreased chenodeoxycholic acid (CDCA), increased concentration of bile alcohols and their glyconjugates, and increased concentrations of cholestanol and apolipoprotein B in cerebrospinal fluid.
Lipase deficiency, combined
MedGen UID:
340886
Concept ID:
C1855498
Disease or Syndrome
A rare disorder caused by mutation in the LMF1 gene resulting in combined lipase deficiency with concomitant hypertriglyceridemia and associated disorders.
Sitosterolemia 1
MedGen UID:
440869
Concept ID:
C2749759
Disease or Syndrome
Sitosterolemia is characterized by: Hypercholesterolemia (especially in children) which (1) shows an unexpected significant lowering of plasma cholesterol level in response to low-fat diet modification or to bile acid sequestrant therapy; or (2) does not respond to statin therapy; Tendon xanthomas or tuberous (i.e., planar) xanthomas that can occur in childhood and in unusual locations (heels, knees, elbows, and buttocks); Premature atherosclerosis, which can lead to angina, aortic valve involvement, myocardial infarction, and sudden death; Hemolytic anemia, abnormally shaped erythrocytes (stomatocytes), and large platelets (macrothrombocytopenia). On occasion, the abnormal hematologic findings may be the initial presentation or the only clinical feature of this disorder. Arthritis, arthralgias, and splenomegaly may sometimes be seen and one study has concluded that "idiopathic" liver disease could be undiagnosed sitosterolemia. The clinical spectrum of sitosterolemia is probably not fully appreciated due to underdiagnosis and the fact that the phenotype in infants is likely to be highly dependent on diet.

Professional guidelines

PubMed

Naoumova RP, Neuwirth C, Lee P, Miller JP, Taylor KG, Soutar AK
Atherosclerosis 2004 May;174(1):165-72. doi: 10.1016/j.atherosclerosis.2004.01.020. PMID: 15135266

Recent clinical studies

Etiology

Cho HR, Lee MH, Haw CR
Cutis 1997 Jun;59(6):315-8. PMID: 9218890

Diagnosis

Kazmi A, Frewen J, McDonald B, Davison J, O'Toole E
Clin Exp Dermatol 2022 Dec;47(12):2336-2338. Epub 2022 Oct 17 doi: 10.1111/ced.15394. PMID: 36254377
Derner BS, Hoffman K, Storfa A, Kruse DL, Stone PA
J Foot Ankle Surg 2020 Nov-Dec;59(6):1301-1305. Epub 2020 Aug 15 doi: 10.1053/j.jfas.2020.08.014. PMID: 32958356
Agirbasli D, Hyatt T, Agirbasli M
J Clin Lipidol 2018 Jul-Aug;12(4):863-867. Epub 2018 Apr 26 doi: 10.1016/j.jacl.2018.04.008. PMID: 29784571
Singh RK, Simalti AK
Indian Pediatr 2009 Aug;46(8):727. PMID: 19717865
Kodama H, Masuda T
J Dermatol 1977 Apr;4(2):41-8. doi: 10.1111/j.1346-8138.1977.tb01009.x. PMID: 15461324

Therapy

Lussier-Cacan S, Cantin M, Roy CC, Sniderman AD, Nestruck AC, Davignon J
Clin Invest Med 1986;9(2):94-9. PMID: 3731582

Prognosis

Kodama H, Masuda T
J Dermatol 1977 Apr;4(2):41-8. doi: 10.1111/j.1346-8138.1977.tb01009.x. PMID: 15461324

Clinical prediction guides

Lussier-Cacan S, Cantin M, Roy CC, Sniderman AD, Nestruck AC, Davignon J
Clin Invest Med 1986;9(2):94-9. PMID: 3731582
Kodama H, Masuda T
J Dermatol 1977 Apr;4(2):41-8. doi: 10.1111/j.1346-8138.1977.tb01009.x. PMID: 15461324

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...